Balloon Aortic Valvuloplasty Market Scope And Analysis

  • Report Code : TIPRE00039182
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 160
Buy Now

Balloon Aortic Valvuloplasty Market Analysis, Trends, and Scope 2024 to 2031

Buy Now


Balloon Aortic Valvuloplasty Market Report Scope

Report Attribute Details
Market size in 2023 US$ 125.08 Million
Market Size by 2031 US$ 190.27 Million
Global CAGR (2023 - 2031) 5.4%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product Type
  • Non-Compliant Balloons
  • Semi-Compliant Balloons
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • B Braun SE
  • TT Medical Inc
  • Balton
  • Becton Dickinson and Co
  • Edwards Lifesciences Corp
  • Balt
  • Venus MedTech HangZhou Inc
  • NuMED
  • simeks
  • OSYPKA
  • Balloon Aortic Valvuloplasty Market News and Recent Developments

    The balloon aortic valvuloplasty market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the balloon aortic valvuloplasty market are listed below:

    • Abbott launched its latest-generation TAVI system, Navitor, in India, making the minimally invasive device available for people with severe aortic stenosis who are at high or extreme surgical risk in the country. Navitor features a unique fabric cuff (NaviSeal) that works with the cardiac cycle to minimize or eliminate a backflow of blood across the valve frame, known as paravalvular leak. (Source: Abbott, Press Release, December 2022)
    • Keystone Heart, Ltd., entered into an exclusive distribution agreement with InterValve Medical Inc. to sell and market their portfolio of balloon aortic valvuloplasty products in the US. Under the agreement, Keystone Heart Ltd. began selling the V8 and TAV8 aortic valvuloplasty balloon catheters (InterValve Medical) in the US market. (Source: Keystone Heart, Ltd; Press Release, March 2021)

    Balloon Aortic Valvuloplasty Market Report Coverage and Deliverables

    The “Balloon Aortic Valvuloplasty Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Balloon aortic valvuloplasty market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Balloon aortic valvuloplasty market trends as well as market dynamics such as drivers, restraints, and key opportunities
    • Detailed PEST and SWOT analysis
    • Balloon aortic valvuloplasty market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the balloon aortic valvuloplasty market
    • Detailed company profiles